Large-Scale BIOTRONIK SPIRIT-ICD Study Enrollment Complete

SPIRIT-ICD study explores benefits of intensified diagnostic follow-up and timely therapeutic intervention for high-risk patient groupBERLIN, Germany, July 5, 2012—BIOTRONIK , a leading manufacturer of innovative medical technology, today announced that enrollment is now complete for the much anticipated SPIRIT-ICD study , with 503 patients from 37 sites in 11 countries worldwide registered. The SPIRIT-ICD study was initiated based on findings from